Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04333498 · ClinicalTrials.gov registry record · NA
Use of Antiretroviral (ARV) Drug Levels in Dried Blood Spots (DBS) to Assess and Manage ART Adherence in South Africa
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04333498 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 60 participants.
The verdict
NCT04333498, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a prospective, pilot study of HIV-positive individuals who have been on tenofovir-containing antiretroviral therapy for at least 4 months. The overall goal of this research is to determine the feasibility of giving patients and their providers monthly feedback about Tenofovir-Diphosphate (TFV-DP) drug levels and to examine patient and provider behaviors in response to receiving this information. This study will build upon the Aim 1 observational study and the subsequent patient and providerFeedback Development Workgroups (FDWs).
Interventions
- BEHAVIORAL Feedback on DBS Concentrations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-09-18 |
| Est. Completion | 2022-11-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04333498
The ClinicalTrials.gov registry entry for NCT04333498 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Feedback on DBS Concentrations is the first listed.
NCT04333498 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04333498 about?
NCT04333498 is a clinical study titled "Use of Antiretroviral (ARV) Drug Levels in Dried Blood Spots (DBS) to Assess and Manage ART Adherence in South Africa". This is a prospective, pilot study of HIV-positive individuals who have been on tenofovir-containing antiretroviral therapy for at least 4 months. The overall goal of this research is to determine the feasibility of giving patients and their providers monthly feedback about Tenofovir-Diphosphate (TF...
What is the current status of trial NCT04333498?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-09-18. Estimated completion is 2022-11-29.
What interventions are being tested in trial NCT04333498?
The interventions under investigation include: Feedback on DBS Concentrations (BEHAVIORAL).
Who is sponsoring clinical trial NCT04333498?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.